U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C11H14N3O3.Br.BrH
Molecular Weight 397.063
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PDM-08

SMILES

Br.[Br-].N[C@]2(C[N+]1=CC=CC=C1)C[C@@H](NC2=O)C(O)=O

InChI

InChIKey=GIZKBHWITTWBAP-IEQXMABBSA-N
InChI=1S/C11H13N3O3.2BrH/c12-11(7-14-4-2-1-3-5-14)6-8(9(15)16)13-10(11)17;;/h1-5,8H,6-7,12H2,(H-,13,15,16,17);2*1H/t8-,11+;;/m1../s1

HIDE SMILES / InChI

Molecular Formula BrH
Molecular Weight 80.912
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C11H13N3O3
Molecular Weight 235.2392
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 11:37:10 GMT 2023
Edited
by admin
on Sat Dec 16 11:37:10 GMT 2023
Record UNII
869R8A3UZS
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PDM-08
Common Name English
(2R,4S)-4-AMINO-5-OXO-4-(1-PYRIDYLMETHYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROBROMIDE
Systematic Name English
PYRIDINIUM, 1-(((3S,5R)-3-AMINO-5-CARBOXY-2-OXO-3-PYRROLIDINYL)METHYL)-, BROMIDE, HYDROBROMIDE (1:1:1)
Systematic Name English
Code System Code Type Description
CAS
953074-84-5
Created by admin on Sat Dec 16 11:37:10 GMT 2023 , Edited by admin on Sat Dec 16 11:37:10 GMT 2023
PRIMARY
SMS_ID
300000010720
Created by admin on Sat Dec 16 11:37:10 GMT 2023 , Edited by admin on Sat Dec 16 11:37:10 GMT 2023
PRIMARY
PUBCHEM
24826985
Created by admin on Sat Dec 16 11:37:10 GMT 2023 , Edited by admin on Sat Dec 16 11:37:10 GMT 2023
PRIMARY
FDA UNII
869R8A3UZS
Created by admin on Sat Dec 16 11:37:10 GMT 2023 , Edited by admin on Sat Dec 16 11:37:10 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY
Originator: Laboratoires Prodimed; Class: Amino acid, Antineoplastic, Pyridinium compound; Mechanism of Action: Immunomodulator; Orphan Drug Status: Yes for Renal cancer; Highest Development Phase: Phase I for Solid tumours; Most Recent Event: 11 Jul 2011 Phase-I clinical trials in Solid tumours in Spain (unspecified route)